Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mometasone Furoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 4/20 | 1.00 |
| ▸ | PGR | P06401 | 4/20 | 1.00 |
| ▸ | AR | P10275 | 3/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 4/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.64 |
| ▸ | CNR1 | P21554 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mometasone Furoate SCHEMBL8430908 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL12996648 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL4896227 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL8826257 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL7436523 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL25382496 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL2594997 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL13026146 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL600107 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL4484 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 29009 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104312-A1 | STABLE MOMETASONE FUROATE COMPOSITIONS | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2026-05-21 | — | — | WO | claimed |
| EP-4744657-A1 | THERAPEUTIC AGENT FOR HUMAN GRAFT VERSUS HOST DISEASE AND COMBINATION THEREOF | National University Corporation Okayama University (JP) | 2026-05-20 | — | — | EP | claimed |
| CN-122057085-A | External auditory canal degradable and self-adaptive drug stent with combined drug release in segmented mode and preparation method thereof | 上海交通大学医学院附属瑞金医院 | 2026-05-19 | — | — | CN | claimed |
| CN-122031290-A | Percutaneous permeation promoting system and preparation method and application thereof | 北京工商大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| EP-4739295-A1 | AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE FOR THE TREATMENT OF ASTHMA | Norton (Waterford) Limited (IE) | 2026-05-13 | — | — | EP | claimed |
| EP-4739294-A1 | AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE FOR THE TREATMENT OF ASTHMA | Norton (Waterford) Limited (IE) | 2026-05-13 | — | — | EP | claimed |
| CN-122005510-A | Momordant mometasone furoate dry powder inhalant without carrier and preparation method thereof | 江苏德迈药业有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| WO-1991007169-A1 | GLYCERYL ACETATE OINTMENT VEHICLES | DOW GORDON JAY (US) | 1991-05-30 | — | — | WO | claimed |
| EP-0262681-B1 | ANTI-INFLAMMATORY CREAM COMPOSITION | SCHERING CORPORATION (US) | 1991-04-24 | — | — | EP | claimed |
| EP-0362270-A1 | STEROID LOTION. | SCHERING CORP (US) | 1990-04-11 | — | — | EP | claimed |
| EP-0318522-A1 | ANTI-INFLAMMATORY CREAM COMPOSITION | SCHERING CORPORATION (US) | 1989-06-07 | — | — | EP | claimed |
| US-4808610-A | STABILITY, PREGNADIENE COMPOUND | SCHERING CORPORATION (US) | 1989-02-28 | — | — | US | claimed |
| WO-1988009174-A1 | STEROID LOTION | SCHERING CORPORATION (US) | 1988-12-01 | — | — | WO | claimed |
| EP-0292893-A1 | Steroid lotion | SCHERING CORPORATION (US) | 1988-11-30 | — | — | EP | claimed |
| US-4775529-A | ANTIINFLAMMATORY, VASOCONSTRICTION; PROPYLENE GLYCOL; ISOPROPANOL AND THICKENER; SKIN DISORDERS | SCHERING CORPORATION (US) | 1988-10-04 | — | — | US | claimed |
| WO-1988002257-A1 | ANTI-INFLAMMATORY CREAM COMPOSITION | SCHERING CORPORATION (US) | 1988-04-07 | — | — | WO | claimed |
| EP-0262681-A1 | Anti-inflammatory cream composition | SCHERING CORPORATION (US) | 1988-04-06 | — | — | EP | claimed |